Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Hypertension. 2013 Feb 25;61(4):842–849. doi: 10.1161/HYPERTENSIONAHA.111.00080

Figure 3.

Figure 3

Change of PVN p44/42 MAPK activity at 1 week and 2 weeks after early (A and B) or late (C and D) PVN microinjections of p44/42 siRNA, a scrambled siRNA, or vehicle in ANG II-infused rats. Untreated rats served as Control. Representative Western blots are aligned with the matching grouped data. Values are corrected by β-actin and expressed as mean ± SEM (n=4 for each group). *P< 0.05, vs. Control; †P< 0.05, ANG II + p44/42 siRNA vs. ANG II + vehicle or ANG II + scrambled siRNA.